Wat is de prijs voor Imaging Biometrics Ltd. (IBAI)

Het prijs van Imaging Biometrics Ltd. (IBAI) is $0.01197417

Wat is de marktkapitalisatie voor Imaging Biometrics Ltd. (IBAI)

Marktkapitalisatie voorImaging Biometrics Ltd. (IBAI) is $29.54K

Imaging Biometrics Ltd. (IBAI) Uitstaande Aandelen

Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and the United States. Its operations are structured into three main segments: a Holding Company, Medical Software, and Oral Gallium Maltolate (GaM). The Medical Software division develops a comprehensive suite of ready-to-use software applications for the healthcare sector. This portfolio includes IB Clinic, which serves as the foundational platform for all IB software; IB Neuro, a specialized platform for MR DSC perfusion processing; and IB Delta Suite, designed to generate Delta T1 maps from routine MR examinations. Further offerings comprise IB DCE and IB Diffusion, both providing in-depth insights into blood flow and water diffusion throughout the body. For non-invasive assessments, the company provides StoneChecker and Liver Surface Nodularity, which are computed tomography (CT) processing tools that assist clinicians in evaluating kidney stones and liver health. Additional software includes IB ASL, used to measure cerebral blood flow for diagnosing conditions like stroke and dementia, and IB Zero G, an innovative technology that eliminates the need for gadolinium contrast agents in standard imaging. The suite also features IB Nimble, facilitating virtual collaboration among healthcare professionals. Beyond software, the company's Oral Gallium Maltolate (GaM) segment is actively pursuing the development of IB003, a gallium maltolate drug candidate currently in Phase 1 clinical trials for treating glioblastoma. Imaging Biometrics Ltd. also offers consulting services. The entity, which was previously known as IQ-AI Limited, is slated to adopt the name Imaging Biometrics Ltd. in May 2025.

Jaar	Uitstaande aandelen	Wijzigen
2026 (TTM)	221.71M	1.72%
2024	217.95M	18.65%
2023	183.70M	0.60%
2022	182.61M	5.70%
2021	172.76M	16.72%
2020	148.01M	15.45%
2019	128.20M	36.90%
2018	93.64M	87.81%
2017	49.86M	69.15%
2016	29.48M	0.00%
2015	29.48M	6.52%
2014	27.67M	0.00%
2013	27.67M	0.00%
2012	27.67M	0.00%
2011	27.67M	0.45%
2010	27.55M	9.14%
2009	25.24M	1.50%
2008	24.87M	0.02%
2007	24.86M	0.11%
2006	24.84M	-3.56%
2005	25.75M	-0.17%
2004	25.80M	-1.26%
2003	26.12M	-0.43%
2002	26.24M	0.00%
2001	26.24M	-0.67%
2000	26.41M	0.00%

Jaar

Uitstaande aandelen

Wijzigen

2026 (TTM)

221.71M

1.72%

2024

217.95M

18.65%

2023

183.70M

0.60%

2022

182.61M

5.70%

2021

172.76M

16.72%

2020

148.01M

15.45%

2019

128.20M

36.90%

2018

93.64M

87.81%

2017

49.86M

69.15%

2016

29.48M

0.00%

2015

29.48M

6.52%

2014

27.67M

0.00%

2013

27.67M

0.00%

2012

27.67M

0.00%

2011

27.67M

0.45%

2010

27.55M

9.14%

2009

25.24M

1.50%

2008

24.87M

0.02%

2007

24.86M

0.11%

2006

24.84M

-3.56%

2005

25.75M

-0.17%

2004

25.80M

-1.26%

2003

26.12M

-0.43%

2002

26.24M

0.00%

2001

26.24M

-0.67%

2000

26.41M

0.00%

Bedrijf	Uitstaande aandelen	Verschil	Land
GE HealthCare Technologies Inc. GEHC.US	453.00M	104.32%	US
Tempus AI, Inc. TEM.US	179.92M	-18.85%	US
Pro Medicus Limited PME.AX	104.47M	-52.88%	AU
BrightSpring Health Services, Inc. Common Stock BTSG.US	205.38M	-7.36%	US
10x Genomics, Inc. TXG.US	129.98M	-41.37%	US

Bedrijf

Uitstaande aandelen

Verschil

Land